Clinical Report: Can Blood Filtration Reduce PFAS?
Overview
Preliminary data suggest that therapeutic apheresis may reduce circulating PFAS levels alongside lipoproteins in patients. The study indicates that blood filtration techniques could address environmental contaminants.
Background
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants linked to various health issues. Current clinical guidelines emphasize exposure reduction and screening rather than direct removal of PFAS from the body. Understanding the efficacy of blood filtration methods could provide insights into managing PFAS exposure.
Data Highlights
| Measurement | Reduction |
|---|---|
| PFOA | Up to 25% |
| PFOS | Up to 25% |
| PFNA | Up to 25% |
| PFHxS | Up to 25% |
Key Findings
- Therapeutic apheresis significantly reduced C-reactive protein, fibrinogen, LDL cholesterol, and lipoprotein(a) in 34 patients.
- Independent laboratory analyses showed reductions in PFAS levels in patient samples, with one lab reporting up to 25% reduction in multiple PFAS compounds.
- Polyethylene and polyvinyl chloride levels decreased in blood samples from patients undergoing treatment.
- Raman spectroscopy indicated lower cholesterol- and lipid-associated spectral bands post-treatment.
- Findings remain preliminary, with no established clearance mechanism for PFAS and microplastics.
Clinical Implications
The study indicates that therapeutic apheresis may reduce certain environmental contaminants in addition to its established use for lipid disorders. However, the clinical application of these findings is limited by the preliminary nature of the data.
Conclusion
Therapeutic apheresis shows reductions in PFAS levels in blood; further studies are necessary to confirm these findings.
Related Resources & Content
- Technische Universität Dresden, Source, 2024 -- Can Blood Filtration Reduce PFAS?
- ATSDR, Clinical Evaluation and Management: PFAS Information for Clinicians - 2024
- Substantial decrease of PFAS with anion exchange resin treatment - A clinical cross-over trial
- the analytical scientist — Portable PFAS Profiling
- the analytical scientist — Elevated PFAS Linked to Changes in Blood Lipids
- Archives of Toxicology — Concentrations of PFC/PFAS in Human Breast Milk and Infant Exposure via Lactation: An In-Depth Review of Existing Research
- the analytical scientist — Demystifying PFAS Testing
- Portable PFAS Profiling
- Elevated PFAS Linked to Changes in Blood Lipids
- Clinical Evaluation and Management: PFAS Information for Clinicians - 2024 | PFAS and Your Health | ATSDR
- Substantial decrease of PFAS with anion exchange resin treatment - A clinical cross-over trial - PubMed
- Extracorporeal Removal of Per- and Polyfluoroalkyl Substances by Hemoadsorption: In vitro Kinetic Model. | EBSCOhost
Based on findings from:
Can Blood Filtration Reduce PFAS?
The Analytical Scientist, 2026.
https://theanalyticalscientist.com/issues/2026/articles/august/can-blood-filtration-reduce-pfas/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
